In 2023, Thomas W. Elward earned $757.79K in total compensation at Dyne Therapeutics, Inc., including $497.89K salary and $258.90K bonus. Most recently acquired 5,000 shares in Mar 2011. Has led Dyne Therapeutics, Inc. for over 13 years.
Compensation History
Annual executive compensation data for Thomas W. Elward, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$757.79K
Salary
$497.89K
Bonus
$258.90K
Other
$996.00
Salary
$497.89KBoard Justification
The compensation philosophy aligns with company performance, peer benchmarking, and retention strategies, focusing on motivating executives to achieve short- and long-term results.
Bonus
$258.90KBoard Justification
The bonus is based on individual and corporate performance metrics established by the board of directors for the year 2023.
Other Compensation
$996.00Board Justification
Other compensation includes long-term disability insurance premiums and group term life insurance premiums in excess of statutory limits.
Restricted Stock
Board Justification
No stock was reported as vested in 2023.
Performance Metrics
Performance metrics include individual and corporate performance goals set by the board of directors.
Thomas W. Elward
CEO of Dyne Therapeutics, Inc.
Sector of Economy
Healthcare
Born
July 30, 2024 - 1 years ago
CEO of Dyne Therapeutics, Inc. for
13 years 11 months (Dec 2011 - Present)
Previous Experience
Unknown
Holdings
Track Thomas W. Elward's stock holdings and portfolio value over time.
Insider Trading
Thomas W. Elward's recent stock transactions, purchases, and sales filed with the SEC.
Rivals
Compare Thomas W. Elward with competitor CEOs and industry peers.